Thomas Kendris is US Country President, US Country Head of Legal and President of Novartis Corporation. In his role as US Country President, Tom is responsible for all Novartis corporate functions represented in the US. He has oversight of 23,500 associates across Novartis US group companies in three divisions including Pharmaceuticals, Alcon, and Sandoz as well as the Novartis Institutes for BioMedical Research. He is also Chairman of the Country Executive Committee (CEC), leading the country strategy for government relations, external affairs and the Novartis corporate reputation in the US.
As US Country Head of Legal, he has country-level responsibility for Legal across all Novartis US divisions. In this role, Tom acts as chief legal advisor to the US Novartis Group of companies and is accountable for leading Novartis-wide material litigations and investigations in the US.
In his more than 20 years with Novartis, Tom has served as Vice President and General Counsel of US Pharma at Novartis Pharmaceuticals Corporation (NPC) as well as General Counsel for Novartis Vaccines and Diagnostics and for Novartis Oncology. He joined Ciba Geigy, a predecessor company of Novartis, in 1995, and was Director/Executive Director, Pharmaceuticals Counsel, for the US Transplant Business Unit and the Mass Market Business Unit.
Earlier in his career, Tom was with the law firm of Mudge Rose Guthrie Alexander & Ferdon. He also served as Deputy Trial Bureau Chief and Assistant District Attorney with the New York County District Attorney’s Office.
He received his Juris Doctor from Fordham University School of Law and his Bachelor of Arts from Wagner College.